Liquid Biopsy Conference 2027 | Sponsor ImmunoMark

The platform-vendor problem

Why a liquid biopsy conference inside an oncology summit sells better

A dedicated liquid biopsy conference is full of people who already understand your technology, and many of them sell a competing one. ImmunoMark works the other way round: liquid biopsy, spatial biology, multiplex imaging, digital pathology and single-cell methods appear as applications inside oncology programmes, so the people in the room are the end users with budgets.

That matters for a platform vendor. Your sale rarely depends on convincing another technologist that your chemistry or optics are good. It depends on a translational lead, a biomarker strategy head or a precision medicine director deciding that your platform answers a question their programme needs answered before the next clinical milestone.

ImmunoMark’s Stream 2, Biomarkers & Companion Diagnostics, is where those people sit. The audience profile is 55–60% biotech and pharma, 45–50% senior leadership and 20–30% scientists, principal investigators and technologists, which gives you both the evaluator and the budget holder at the same event.

22027 editions with Stream 2 content: San Diego and London

55–60%biotech and pharma in the audience profile

45–50%senior leadership: executives, directors and heads

15–25meetings per sponsor at London 2026

Real 2027 agenda content

Where each platform shows up on the 2027 agendas

Both editions put these technologies on the programme as tools for oncology questions. This table maps your platform to real sessions, labelled by edition.

Platform	San Diego, 10–11 Feb 2027	London, 3–4 Mar 2027
Liquid biopsy, ctDNA, MRD	Day 1, Stream 2: The Growing Role of Liquid Biopsy and Minimal Residual Disease Monitoring in Personalised Cancer Care (Hadly Clark, FasterCures, Milken Institute)	Stream 2 key highlight: multi-omics, spatial biology and liquid biopsy platforms
Spatial biology	Day 1, Stream 2: Beyond Spatial Omics: Multimodal Measurement as Infrastructure for Precision Medicine (Ivan Lebedev, Verdant Center for Spatial Biology)	Day 1, Stream 2: Leveraging Space Genomics to Discover Novel Biomarkers and Identify Emerging Therapeutic Strategies (Norris Igbineweka, Vertex Pharmaceuticals)
Digital pathology	Day 1, Stream 2: Panel Discussion: How AI-Driven Digital Pathology is Transforming Biomarker Discovery and Precision Medicine (Sripad Ram, Pfizer)	Day 1, Stream 2: Digital Pathology & Spatial Transcriptomics in Oncology
Multiplex imaging and multiplex assays	Day 1, Stream 2: Leveraging Multi-Omics Technologies to Identify Predictive Biomarkers for Precision Oncology	Day 2, Stream 2: Multiplex & Programmable Biomarker Platforms
Single-cell and functional assays	Day 2, Stream 2: Single-Cell Technologies and Functional Biomarkers Driving the Future of Precision Oncology	Day 2, Stream 2: Functional T cell Biomarkers for Precision Immuno-Oncology (Marc Vendrell, The University of Edinburgh)

The same themes ran through London 2026, where Stream 2 covered liquid biopsy and real-time monitoring, multi-omics and single-cell technologies, and AI-driven biomarker discovery platforms. For a primer on one of the choices your buyers face, see our article on spatial proteomics vs spatial transcriptomics.

Platform by platform

What the room is buying, by technology

Each platform category meets a different buyer question at ImmunoMark. Pitch to the question, not the specification sheet.

Liquid biopsy and ctDNA

Unlike a ctDNA conference where the debate is about limits of detection, the conversations here are about MRD monitoring and longitudinal response in immunotherapy programmes. Bring data from a treated cohort, not an analytical sensitivity slide.

Spatial biology

A spatial biology conference audience wants new methods. This audience wants to know whether tissue context explains why patients respond to immunotherapy, and whether your platform can scale from a discovery cohort to trial samples.

Multiplex imaging and digital pathology

Where a multiplex imaging conference or a digital pathology conference focuses on panels, scanners and algorithms, ImmunoMark buyers ask how image-based readouts become reproducible biomarkers that regulators and pathologists will accept.

Single-cell

As a single-cell conference in oncology, ImmunoMark is narrow by design: immune cell states, resistance and functional biomarkers. Your best opening is a translational question your platform has already answered for a similar programme.

If you sell discovery tools in the US specifically, the San Diego discovery-tools page goes deeper on that edition. For the UK and the Oxford, Cambridge and London cluster, see the London oncology biomarker page.

Package fit

Which packages fit liquid biopsy and spatial platform vendors

Platform vendors need a physical place to show the technology and a schedule of conversations with end users. The packages below do both, and every one is available at each edition.

Best fit

Exhibitor + 1:1 Meetings

A booth for show-and-tell material and data, paired with an Exclusive 1:1 Meetings package to book the end users you choose. Practical to repeat in both cities.

10 x 6 ft booth with 2 + 2 passes
Add 3, 5, 7 or 10 pre-arranged 20-minute meetings
Wishlist for targeted engagement
Delegate list with contact details
Website and brochure logo

Exclusive 1:1 Meetings

For vendors whose platform is best explained across a table with the buyer’s own data question in front of you.

3, 5, 7 or 10 pre-arranged 20-minute meetings
2–4 delegate passes
Drinks reception passes
Delegate list and wishlist

Platinum (Stream 2)

For a platform with a strong application case study to present on Day 1, in the block where the liquid biopsy, spatial and digital pathology content runs.

30-minute Day 1 talk in Stream 2
10 pre-scheduled 1:1 meetings
10 x 6 ft booth and a 1-minute video promotion
8 delegate + 8 client passes

Every tier includes the delegate list with contact details and post-event branding. Booths at Exhibitor and stream tiers are 10 x 6 ft with a table, two chairs and a power outlet; check any larger instrument with the organiser in advance.

Tell us your platform and target edition, and we will match a package to it.

Request the prospectus

One edition or two

San Diego, London or both

San Diego, 10–11 February 2027

The US launch edition with 300+ senior delegates expected. The strongest Stream 2 line-up for liquid biopsy, spatial and digital pathology on a single day (Day 1). See the San Diego sponsorship opportunities.

London, 3–4 March 2027

The 2nd annual edition, targeting 400+ delegates, 60% from the UK and Ireland and 40% from the rest of Europe. London 2026 delivered 200+ meetings and 15–25 meetings per sponsor. See the London sponsorship opportunities.

Boston follows in June 2027 as a third launch edition. Vendors with US and European customers can run the same platform story about three weeks apart in San Diego and London. For a wider comparison of all three editions for biomarker sponsors, read the biomarker conference sponsorship guide.

What sponsors said

Feedback from London 2026 sponsors

Here is what sponsors told us at our London 2026 launch edition.

We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

Project Manager

PromoCell GmbH · Sponsor, London 2026

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

BD Manager Europe

Secretech · Sponsor, London 2026

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

Research Account Manager

Miltenyi Biotec · Sponsor, London 2026

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

Senior Business Development Director Europe

Rouken Bio · Sponsor, London 2026

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

Epigenomics Applications Specialist

Hologic Diagenode · Sponsor, London 2026

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Biopharma Business Development Manager EMEA

Hologic Diagenode · Sponsor, London 2026

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

Business Development Executive

HistologiX · Sponsor, London 2026

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Product Specialist

HAWK Biosystems · Sponsor, London 2026

Get the prospectus

Frequently asked questions

Is ImmunoMark a dedicated liquid biopsy conference?

No, and that is the point for a platform vendor. ImmunoMark is an oncology summit with two streams, Next-Gen Immuno-Oncology and Biomarkers & Companion Diagnostics. Liquid biopsy, spatial, multiplex imaging, digital pathology and single-cell methods are discussed as applications in oncology programmes, so you meet the teams who would buy and use your platform.

Which edition has more spatial and digital pathology content?

Both have it. San Diego (Day 1, Stream 2) has a spatial omics session from the Verdant Center for Spatial Biology and an AI-driven digital pathology panel with Pfizer. London has Digital Pathology & Spatial Transcriptomics in Oncology on Day 1 and Multiplex & Programmable Biomarker Platforms on Day 2.

Can we show an instrument on our booth?

The standard booth at Exhibitor, Silver, Gold and Platinum level is 10 x 6 ft with a table, two chairs and a power outlet. The Headline package includes a 20 x 12 ft space. Check the size and power needs of any instrument with the organiser before the event.

Can we sponsor San Diego and London together?

Yes. The packages are the same at every edition, so you can run the same platform story in San Diego (10–11 February 2027) and London (3–4 March 2027), and add Boston in June 2027 if you also sell on the US East Coast.

Who are the buyers for a platform vendor at ImmunoMark?

Translational medicine, biomarker strategy and precision medicine teams at biotech and pharma companies, plus academic groups. The audience profile is 55–60% biotech and pharma, 10–15% academic and 45–50% senior leadership, with 20–30% scientists, principal investigators and technologists.

Liquid Biopsy Conference Sponsorship: Meet Oncology End Users

Get the prospectus and package availability